In a mouse breast cancer model, an anti-TGFβ antibody inhibits TAM-mediated NK cell suppression in vitro, and a selective TGFβ receptor antagonist partially but significantly suppresses early metastatic tumour growth when combined with NK cell infusion in vivo [33]. Here, TGFB1 is linked to breast carcinoma.